Literature DB >> 9453051

Apoptosis: a new pharmacodynamic endpoint.

J L Au1, N Panchal, D Li, Y Gan.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9453051     DOI： 10.1023/a:1012159208559

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  186 in total

1.  Effect of bcl-2 on Fas antigen-mediated cell death.

Authors:  N Itoh; Y Tsujimoto; S Nagata
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

2.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

3.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 4.  The biochemistry of programmed cell death.

Authors:  G Kroemer; P Petit; N Zamzami; J L Vayssière; B Mignotte
Journal:  FASEB J       Date:  1995-10       Impact factor: 5.191

5.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

6.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

7.  Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.

Authors:  E J Fuchs; A Bedi; R J Jones; A D Hess
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

8.  Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

Authors:  T G Graeber; J F Peterson; M Tsai; K Monica; A J Fornace; A J Giaccia
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

9.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme.

Authors:  J Yuan; S Shaham; S Ledoux; H M Ellis; H R Horvitz
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

Authors:  S A Susin; N Zamzami; M Castedo; T Hirsch; P Marchetti; A Macho; E Daugas; M Geuskens; G Kroemer
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307
View more
  11 in total

Review 1.  Differential response of the tail and body epidermis of Rana catesbeiana tadpoles in vitro to the anticancer drug, cisplatin.

Authors:  J Menon; M Z Wahrman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

2.  Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.

Authors:  T Minko; P Kopecková; J Kopecek
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 3.  Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death.

Authors:  A N Kong; S Mandlekar; R Yu; W Lei; A Fasanmande
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

4.  Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein.

Authors:  D Li; J L Au
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

5.  Modulation of tumor necrosis factor-mediated cell death by fullerenes.

Authors:  Ljubica Harhaji; Aleksandra Isakovic; Ljubica Vucicevic; Kristina Janjetovic; Maja Misirkic; Zoran Markovic; Biljana Todorovic-Markovic; Nadezda Nikolic; Sanja Vranjes-Djuric; Zoran Nikolic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 6.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

Review 7.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.

Authors:  Chi-Chen Lu; Mei-Yi Lin; Syue-Yi Chen; Cheng-Huang Shen; Lih-Geeng Chen; Hsiao-Yen Hsieh; Michael W Y Chan; Cheng-Da Hsu
Journal:  BMC Complement Altern Med       Date:  2013-02-23       Impact factor: 3.659

9.  Evaluation of the anticancer potential of six herbs against a hepatoma cell line.

Authors:  Natthida Weerapreeyakul; Apiyada Nonpunya; Sahapat Barusrux; Thaweesak Thitimetharoch; Bungorn Sripanidkulchai
Journal:  Chin Med       Date:  2012-06-10       Impact factor: 5.455

10.  Synergistic effects of melphalan and Pinus kesiya Royle ex Gordon (Simaosong) extracts on apoptosis induction in human cancer cells.

Authors:  Natthida Weerapreeyakul; Sasipawan Machana; Sahapat Barusrux
Journal:  Chin Med       Date:  2016-06-29       Impact factor: 5.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.